Routine shareholder approval of equity plan — no immediate trading catalyst. Monitor future 8-K filings for actual grant activity under the new plan, which could signal management's compensation strategy.
Price Chart
Executive Summary
Chemours shareholders approved the 2026 Equity and Incentive Plan at the April 24, 2026 annual meeting, authorizing up to 6,375,275 shares for future equity grants to employees, directors, and consultants. All 11 director nominees were elected and say-on-pay was approved. This is a routine governance filing with no material financial impact.
Key Facts
- Shareholders approved the 2026 Equity and Incentive Plan with 108,842,885 votes for, 3,734,567 against, and 238,082 abstentions.
- The plan authorizes a maximum of 6,375,275 shares for issuance, less one share for every share granted under the prior plan after March 2, 2026.
- All 11 director nominees were elected with support ranging from 95.8% to 99.3% of votes cast.
- Say-on-pay advisory vote passed with 110,058,427 votes for and 2,527,583 against.
- PricewaterhouseCoopers LLP was ratified as independent auditor with 128,312,790 votes for.
- The plan replaces the 2017 Equity and Incentive Plan; no new awards will be granted under the prior plan going forward.
Financial Impact
No immediate financial impact. The plan authorizes up to 6,375,275 shares for future equity compensation, representing approximately 1.7% of shares outstanding at a $4.0B market cap.
Risk Factors
- Potential future dilution from equity grants under the new plan, though capped at ~6.4M shares.
- No material financial or operational risks identified in this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-193216 |
| Document: cc-20250422.htm | 0001193125-26-193216 |
| Document: 0001193125-26-193216-index-headers.html | 0001193125-26-193216 |
| Document: 0001193125-26-193216-index.html | 0001193125-26-193216 |
| Document: 0001193125-26-193216.txt | 0001193125-26-193216 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 22d ago | 8-K | $15.07 $14.44 | ▼ −4.18% | ▼ −3.68% | $13.71 (−9.02%) |
Sep 9, 2026 23d ago | 8-K | $15.04 $14.73 | ▼ −2.06% | ▼ −1.73% | $13.71 (−8.84%) |
Aug 14, 2026 6w ago | Institutional Cluster | $15.72 $15.39 | ▲ +2.10% | ▲ +0.91% | $13.71 (+12.79%) |
Aug 13, 2026 7w ago | Insider Cluster | $15.26 $15.69 | ▲ +2.82% | ▲ +4.78% | $13.71 (−10.16%) |
Aug 11, 2026 7w ago | Insider Cluster | $14.80 $15.42 | ▲ +4.19% | ▲ +4.59% | $13.71 (−7.36%) |
Aug 4, 2026 8w ago | Press Release | $14.59 $15.24 | ▼ −4.46% | ▼ −4.10% | $13.71 (+6.03%) |
Aug 4, 2026 8w ago | Press Release | $14.59 $15.24 | ▲ +4.46% | ▲ +4.10% | $13.71 (−6.03%) |
Jul 23, 2026 10w ago | Press Release | $17.22 $17.11 | ▼ −0.64% | ▼ −1.01% | $13.71 (−20.38%) |
Jun 3, 2026 17w ago | Court Ruling | $22.61 $20.31 | ▼ −10.17% | ▼ −6.35% | $13.71 (−39.36%) |
May 5, 2026 21w ago | 8-K | $23.67 $24.67 | ▲ +4.22% | ▲ +3.09% | $13.71 (−42.08%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access